Related Experiment Videos
[Atopic dermatitis is not an allergic disease]
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Simple method to predict lymphocyte collection for chimeric antigen receptor T-cell engineering.
Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine·2025
[Suspected allergy to COVID-19 vaccines: A retrospective study of 320 patients].
Revue francaise d'allergologie (2009)·2023
Therapeutic management of adults with atopic dermatitis: comparison with psoriasis and chronic urticaria.
Journal of the European Academy of Dermatology and Venereology : JEADV·2020
[NSAID urticaria: Similar management to acute urticaria].
La Revue de medecine interne·2019
ALK7 expression in prolactinoma is associated with reduced prolactin and increased proliferation.
Endocrine-related cancer·2018
Epidermolysis bullosa simplex generalized severe induces a T helper 17 response and is improved by apremilast treatment.
The British journal of dermatology·2018
Predictive analytics and risk stratification models in internal medicine: from risk scores to real-time machine learning.
Presse medicale (Paris, France : 1983)·2026
Artificial Intelligence in skin disease therapeutics: from drug discovery to personalized treatment pathways.
Presse medicale (Paris, France : 1983)·2026
AI in clinical diagnostics in dermatology: applications, validation, and real-world use cases.
Presse medicale (Paris, France : 1983)·2026
Artificial Intelligence in medical research and publishing: Progress, risks, and future perspectives.
Presse medicale (Paris, France : 1983)·2026
Ethical, legal, and regulatory challenges in AI-based healthcare tools.
Presse medicale (Paris, France : 1983)·2026
Beyond one-size-fits-all: Personalising health communication to drive real behaviour change.
Presse medicale (Paris, France : 1983)·2026
Upadacitinib for refractory generalized lichen sclerosus: a case report and brief literature review.
Frontiers in immunology·2026
Case Report: A case report of bullous pemphigoid triggered by sintilimab (PD-1 inhibitor).
Frontiers in immunology·2026